NM_020964.3:c.5937C>A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_020964.3(EPG5):c.5937C>A(p.Asn1979Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000181 in 1,603,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. N1979N) has been classified as Likely benign.
Frequency
Consequence
NM_020964.3 missense
Scores
Clinical Significance
Conservation
Publications
- Vici syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020964.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EPG5 | NM_020964.3 | MANE Select | c.5937C>A | p.Asn1979Lys | missense | Exon 34 of 44 | NP_066015.2 | ||
| EPG5 | NM_001410859.1 | c.5937C>A | p.Asn1979Lys | missense | Exon 34 of 44 | NP_001397788.1 | |||
| EPG5 | NM_001410858.1 | c.5937C>A | p.Asn1979Lys | missense | Exon 34 of 44 | NP_001397787.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EPG5 | ENST00000282041.11 | TSL:1 MANE Select | c.5937C>A | p.Asn1979Lys | missense | Exon 34 of 44 | ENSP00000282041.4 | ||
| EPG5 | ENST00000587884.2 | TSL:1 | n.*1677C>A | non_coding_transcript_exon | Exon 35 of 45 | ENSP00000466990.2 | |||
| EPG5 | ENST00000590884.6 | TSL:1 | n.*532C>A | non_coding_transcript_exon | Exon 34 of 42 | ENSP00000466403.2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152134Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000805 AC: 2AN: 248468 AF XY: 0.00000741 show subpopulations
GnomAD4 exome AF: 0.00000758 AC: 11AN: 1451626Hom.: 0 Cov.: 28 AF XY: 0.00000692 AC XY: 5AN XY: 722920 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000118 AC: 18AN: 152252Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74452 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.5937C>A (p.N1979K) alteration is located in exon 34 (coding exon 34) of the EPG5 gene. This alteration results from a C to A substitution at nucleotide position 5937, causing the asparagine (N) at amino acid position 1979 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Vici syndrome Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 1979 of the EPG5 protein (p.Asn1979Lys). This variant is present in population databases (rs150214973, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with EPG5-related conditions. ClinVar contains an entry for this variant (Variation ID: 534602). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt EPG5 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at